Bisphosphonate Therapy for Patients with Breast Cancer
Journal:
Current Cancer Therapy Reviews
Volume:
1
Page:
217-225
Author(s):
Allan Lipton
Antioxidant Supplements, Genetics and Chemotherapy Outcomes
Journal:
Current Cancer Therapy Reviews
Volume:
1
Page:
251-258
Author(s):
Christine B. Ambrosone, Jiyoung Ahn and Vreni Schoenenberger
IP6 & Inositol in Cancer Prevention and Therapy
Journal:
Current Cancer Therapy Reviews
Volume:
1
Page:
259-269
Author(s):
Abul K.M. Shamsuddin and Ivana Vucenik
An Emerging Molecular Target in Melanoma: Cellular Carbonyl Stress and the Inhibition of Mitochondrial Survival Pathways by Carbonyl Scavenger Agents
Journal:
Current Cancer Therapy Reviews
Volume:
1
Page:
271-276
Author(s):
Georg T. Wondrak, Myron K. Jacobson and Elaine L. Jacobson
Experimental Onco-Immunology Revisited
Journal:
Current Cancer Therapy Reviews
Volume:
1
Page:
289-298
Author(s):
Christiane D. Pasqualini, Raul A. Ruggiero, Oscar D. Bustuoabad, Irene Nepomnaschy and Isabel Piazzon
The IGF-I/IGF-I Receptor Pathway: Implications in the Pathophysiology of Thyroid Cancer
Journal:
Current Medicinal Chemistry
Volume:
12
Page:
2881-2891
Author(s):
A. Ciampolillo, C. De Tullio and F. Giorgino
Hypomethylation of Urokinase (uPA) Promoter in Breast and Prostate Cancer: Prognostic and Therapeutic Implications
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
471-488
Author(s):
Pouya Pakneshan, Moshe Szyf and Shafaat A. Rabbani
Targeting Invasion Induction as a Therapeutic Strategy for the Treatment of Cancer
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
489-503
Author(s):
Donna L. Livant
Control of Copper Status for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
543-549
Author(s):
Vicki L. Goodman, George J. Brewer and Sofia D. Merajver
Cellular and Molecular Surrogate Markers to Monitor Targeted and Non- Targeted Antiangiogenic Drug Activity and Determine Optimal Biologic Dose
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
551-559
Author(s):
Yuval Shaked, Guido Bocci, Raquel Munoz, Shan Man, John M.L. Ebos, Daniel J. Hicklin, Francesco Bertolini, Robert D'Amato and Robert S. Kerbel